New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tilray Brands, Inc.
TLRY.TO
Shape
US Flag

TSX

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Jan 2025

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Jan 2025

2.24CAD
Shape0.05 ( 2.28%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-15%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

44%

Quote Panel

Shape
Updated October 14, 2024
1W -0.88 % 1M -7.82 % 3M -14.83 % 1Y -19.13 %

Key Metrics

Shape
  • Market Cap

    2.02B


  • Shares Outstanding

    903.29M


  • Share in Float

    897.06M


  • Dividende

    0


  • Earning Date

    07 Jan 2025


  • Price Target

    2.24


  • Average Volume

    970703


  • Beta

    2.189


  • Range

    2.0-4.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.tilray.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.86x

P/S Ratio

0.17x

P/B Ratio

0.1

Debt/Equity

-29.1%

Net Margin

$-0.4

EPS

How TLRY.TO compares to sector?

P/E Ratio

Relative Strength

Shape

TLRY.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape442%

2025-Revenue

$0.16

Shape-83%

2025-EPS

$103M

Shape640%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.13
vs NA

Q4.22

arrow
arrow

N/A

-0.11
vs 0.03

Q1.23

arrow
arrow

N/A

-1.90
vs 0.09

Q2.23

arrow
arrow

N/A

-0.18
vs -0.90

Q3.23

arrow
arrow

N/A

-0.10
vs -0.13

Q4.23

arrow
arrow

N/A

-0.07
vs -0.11

Q1.24

arrow
arrow

N/A

-0.12
vs -1.90

Q2.24

arrow
arrow

N/A

-0.04
vs -0.18

Q3.24

arrow
arrow

N/A

-0.05
vs -0.10

Q4.24

arrow
arrow

N/A

-0.05
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-9%

153.2M  vs 168M

Q4.22

arrow
arrow

-7%

144.1M  vs 155.2M

Q1.23

arrow
arrow

-4%

145.6M  vs 151.9M

Q2.23

arrow
arrow

+20%

184.2M  vs 153.3M

Q3.23

arrow
arrow

+15%

176.9M  vs 153.2M

Q4.23

arrow
arrow

+34%

193.8M  vs 144.1M

Q1.24

arrow
arrow

+29%

188.3M  vs 145.6M

Q2.24

arrow
arrow

+25%

229.9M  vs 184.2M

Q3.24

arrow
arrow

+67%

295.3M  vs 176.9M

Q4.24

arrow
arrow

+55%

300M  vs 193.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.10

Q4.22

arrow
arrow

-1%

-0.01
vs -0.01

Q1.23

arrow
arrow

-35%

-0.35
vs -0.01

Q2.23

arrow
arrow

-4%

-0.04
vs -0.35

Q3.23

arrow
arrow

-2%

-0.02
vs -0.04

Q4.23

arrow
arrow

-1%

-0.01
vs -0.02

Q1.24

arrow
arrow

-3%

-0.03
vs -0.01

Q2.24

arrow
arrow

-1%

-0.01
vs -0.03

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News